Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II study of OP-02 for treatment and prevention of chronic otitis media with effusion (COME) in children

Trial Profile

A Phase II study of OP-02 for treatment and prevention of chronic otitis media with effusion (COME) in children

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 29 Oct 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cholesteryl palmitate/colfosceril palmitate (Primary)
  • Indications Otitis media
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 29 Oct 2019 According to a Novus Therapeutics media release, the U.S. Food and Drug Administration (FDA) has agreed with the Company's proposed patient population, endpoints, and statistical analysis plan for this study in patients with chronic otitis media with effusion.
    • 13 Aug 2019 According to a Novus Therapeutics media release, the company anticipates meeting with FDA to discuss the trial in September 2019.
    • 16 Sep 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top